Description: ENDRA Life Sciences Inc. develops photo- and thermo-acoustic medical technologies that bring new capabilities to existing ultrasound systems. Its photo-acoustic solutions help global medical researchers to screen and modify disease models with high image quality and volume scanning speed. The company offers the Nexus-128 system, a fully 3D imaging solution for imaging anatomy, physiology, and labeled molecular targets for institutions. Its thermo-acoustic technology is being developed to enable clinicians to use their existing ultrasound equipment to visualize tissue function, composition, and monitor various therapeutic interventions at the point of care. The company was incorporated in 2007 and is headquartered in Ann Arbor, Michigan.
Home Page: www.endrainc.com
NDRA Technical Analysis
3600 Green Court
Ann Arbor,
MI
48105-1570
United States
Phone:
734 335 0468
Officers
| Name | Title |
|---|---|
| Mr. Francois Michelon | Chairman, Pres & CEO |
| Mr. Michael Thornton | Chief Technology Officer |
| Mr. Renaud Bertrand Maloberti | Chief Commercial Officer |
| Dr. Jonathan Behr Ph.D. | Co-Founder |
| Ms. Irina Pestrikova | Sr. Director of Fin. & Sec. |
| Mr. Steve Freeman | HR Leader |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Equipment & Supplies |
| GIC Sub-Industry: | Health Care Equipment |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.0402 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2017-05-09 |
| Fiscal Year End: | December |
| Full Time Employees: | 22 |